common
marmoset
callithrix
jacchu
new
world
monkey
nwm
speci
small
arbor
nonhuman
primat
nhp
nativ
atlant
coastal
forest
northeast
brazil
part
south
east
brazil
recent
year
common
marmoset
becom
wide
use
appli
biomed
research
increas
bodi
evid
suggest
physiolog
immunolog
respons
biolog
insult
similar
marmoset
human
field
infecti
diseas
marmoset
primarili
investig
altern
nhp
model
complement
tradit
use
old
world
monkey
owm
eg
rhesu
cynomolgu
macaqu
evolutionarili
nwm
owm
sit
within
simiiform
infraord
subord
haplorhini
primat
marmoset
sit
within
famili
callitrichida
platyrrhini
parvord
owm
sit
within
cercopithecida
famili
catarrhini
parvord
marmoset
therefor
separ
old
world
monkey
one
ancestr
step
lower
order
primat
marmoset
use
model
infect
syndrom
caus
number
public
health
pathogen
includ
lassa
viru
hepat
c
viru
dengu
viru
herpesviru
junin
viru
rift
valley
fever
sar
marmoset
also
use
model
number
biodefens
pathogen
includ
eastern
equin
enceph
viru
bacillu
anthraci
francisella
tularensi
burkholderia
pseudomallei
marburg
haemorrhag
fever
viru
ebola
haemorrhag
fever
viru
variola
viru
util
marmoset
assess
medic
countermeasur
also
demonstr
vaccin
test
lassa
fever
efficaci
ciprofloxacin
levofloxacin
test
postexposur
therapi
anthrax
tularemia
respect
order
exploit
model
fulli
allow
meaning
comparison
human
condit
respons
immun
system
infectiontherapi
need
characteris
understood
gener
nhp
close
molecular
immunolog
reproduct
neurolog
similar
human
make
ideal
surrog
human
studi
infecti
diseas
high
level
gene
homolog
human
nhp
underli
physiolog
biochem
similar
similar
genet
level
extend
phenotyp
level
make
nhp
well
suit
model
pathophysiolog
respons
man
immunolog
high
degre
homolog
human
marmoset
similar
variou
immunolog
factor
produc
human
marmoset
investig
genet
protein
level
least
homolog
human
costimulatori
molecul
eg
etc
marmoset
also
immunoglobulin
tcell
receptor
repertoir
human
marmoset
show
least
homolog
current
avail
commerci
reagent
specif
design
marmoset
limit
although
number
antibodi
design
use
human
sampl
shown
crossreact
leucocyt
marmoset
blood
howev
reagent
exploit
investig
immun
respons
infecti
diseas
date
investig
immun
respons
marmoset
primarili
achiev
use
pathogenspecif
antibodi
determin
serolog
respons
use
elisa
smallpox
dengu
rift
valley
fever
herp
model
immunohistochemistri
identifi
exampl
cell
smallpox
model
neutrophil
macrophag
herp
model
cell
lassa
model
work
present
focus
understand
immun
profil
naiv
marmoset
well
identifi
quantifi
immun
respons
infecti
diseas
aim
work
determin
key
chang
identifi
correl
infect
protect
healthi
sexual
matur
common
marmoset
c
jacchu
obtain
dstl
porton
breed
coloni
hous
vasectom
male
femal
pair
dstl
coloni
establish
close
coloni
stabl
genotyp
anim
includ
studi
mix
sex
pair
month
year
old
weigh
g
g
anim
allow
free
access
food
water
well
environment
enrich
anim
studi
carri
accord
uk
anim
scientif
procedur
act
code
practic
hous
care
anim
use
scientif
procedur
anim
challeng
intracellular
pathogen
either
subcutan
inhal
rout
human
kill
variou
time
point
challeng
prior
infect
studi
anim
bled
determin
baselin
immunolog
paramet
studi
perform
establish
infect
model
order
evalu
efficaci
suitabl
therapi
transit
ultim
clinic
blood
tissu
sampl
homogenis
provid
singl
cell
suspens
red
blood
cell
lyse
mix
leucocyt
popul
wash
stain
variou
combin
follow
fluoresc
antibodi
stain
mchii
bd
bioscienc
insight
bioscienc
abd
serotec
sampl
fix
paraformaldehyd
hr
analys
flow
cytometri
facscanto
ii
bd
within
hour
stain
level
circul
cytokin
chemokin
also
quantifi
blood
marmoset
dstl
coloni
use
human
multiplex
kit
avail
commerci
bd
cytokin
flex
bead
luminex
system
system
show
signific
crossreact
marmoset
suggest
high
degre
conserv
two
speci
howev
cytokin
pivot
innat
respons
reagent
obtain
ucytech
bioscienc
mabtech
ab
respect
due
lack
crossreact
observ
within
kit
obtain
bd
order
fulli
characteris
immun
respons
infecti
agent
marmoset
singl
cell
suspens
lung
spleen
tissu
also
examin
conjunct
tradit
use
blood
cell
tissu
homogen
particular
interest
relat
target
site
infect
lung
site
initi
infect
follow
inhal
challeng
spleen
repres
organ
follow
parent
challeng
cell
type
target
analysi
includ
cell
import
innat
respons
eg
neutrophil
macrophag
nk
cell
adapt
respons
b
cell
view
determin
respons
infect
vaccin
deriv
immun
correl
infectionprotect
dapi
includ
nuclear
marker
ensur
initi
gate
includ
intact
cell
basic
cell
type
blood
easili
identifi
measur
size
forward
granular
side
scatter
figur
identif
cell
type
tissu
sampl
difficult
scatter
profil
less
clearli
compartment
common
leukocyt
antigen
normal
use
locat
leukocyt
human
sampl
also
work
well
marmoset
blood
fail
provid
relev
inform
tissu
sampl
confirm
neutrophil
identif
done
nuclear
morpholog
macrophag
identifi
adher
natur
initi
experi
data
shown
neutrophil
stain
dim
macrophag
regardless
tissu
origin
figur
b
figur
c
show
basic
divis
lymphocyt
b
nk
cell
healthi
blood
sampl
use
approach
percentag
nk
cell
bcell
total
tcell
tcell
neutrophil
monocyt
determin
blood
naiv
marmoset
figur
tabl
approxim
lymphocyt
cell
b
cell
nk
cell
variabl
data
depict
figur
greatest
variabl
observ
proport
neutrophil
obviou
differ
attribut
age
sex
anim
analysi
also
appli
lung
spleen
homogen
naiv
marmoset
figur
b
c
greater
variabl
observ
data
relat
identif
cell
type
tissu
sampl
attribut
inher
difficulti
identifi
cell
type
tissu
homogen
size
granular
also
smaller
cohort
anim
expect
low
number
neutrophil
found
naiv
spleen
lung
tissu
healthi
mous
spleen
typic
approxim
granulocyt
understand
report
typic
cell
percentag
expect
healthi
human
individu
tissu
howev
report
b
cell
preval
spleen
human
ratio
b
cell
lung
ratio
b
cell
marmoset
data
report
ratio
b
cell
spleen
b
tcell
lung
observ
compar
ratio
b
cell
mous
spleen
upon
comparison
marmoset
data
gener
consist
previous
report
data
avail
marmoset
blood
sampl
inform
avail
human
blood
tabl
howev
one
report
found
proport
tcell
almost
three
time
greater
marmoset
human
respect
compar
observ
studi
work
previous
report
brok
et
al
brok
studi
involv
small
number
anim
eight
also
use
differ
clone
identifi
cell
contrastingli
mice
differ
observ
proport
b
cell
neutrophil
although
differ
highli
strain
specif
mice
report
b
cell
balbc
mice
consist
higher
percentag
found
marmoset
human
approxim
tabl
proport
neutrophil
found
blood
mice
lower
found
marmoset
expect
healthi
human
blood
encourag
neutrophil
play
pivot
role
innat
respons
infect
crossspeci
comparison
suggest
monocyt
compris
leukocyt
tabl
level
circul
cytokin
chemokin
rant
also
quantifi
blood
lung
spleen
marmoset
dstl
coloni
none
cytokin
detect
blood
sampl
uninfect
anim
howev
low
level
rant
found
spleen
lung
tissu
preliminari
investig
immun
respons
support
develop
marmoset
model
infect
dstl
level
differ
cell
type
measur
specif
time
challeng
inhal
f
tularensi
b
pseudomallei
marburg
viru
follow
challeng
f
tularensi
increas
level
nk
cell
neutrophil
cell
macrophag
observ
peak
hour
challeng
rapidli
declin
studi
also
demonstr
import
investig
immunolog
respons
key
target
organ
increas
cell
cell
observ
spleen
lung
blood
increas
level
variou
cytokin
observ
lung
spleen
blood
diseas
progress
measur
studi
follow
inhal
challeng
marmoset
b
pseudomallei
increas
number
neutrophil
observ
blood
hour
challeng
follow
rapid
declin
associ
influx
neutrophil
lung
hour
challeng
subsequ
declin
number
neutrophil
lung
associ
increas
number
spleen
anim
exhibit
sever
diseas
human
kill
gradual
increas
number
macrophag
spleen
diseas
progress
number
macrophag
peak
blood
lung
hour
challeng
rapid
declin
number
macrophag
lung
blood
observ
hour
challeng
level
variou
cell
type
cytokin
also
measur
blood
anim
follow
inhal
challeng
marburg
viru
anim
gener
increas
number
cell
nk
cell
macrophag
observ
time
measur
order
gain
inform
acut
bacteri
infect
model
sought
marker
literatur
primarili
marmoset
model
autoimmun
disord
rheumatoid
arthriti
multipl
sclerosi
crossreact
human
antibodi
investig
well
function
cell
recent
work
dstl
report
crossreact
marmoset
cell
human
cytokin
induc
activ
marmoset
cell
studi
combin
increas
inform
avail
crossreact
human
antibodi
variou
nhp
eg
nih
nhp
reagent
resourc
http
wwwnhpreagentsorgnhpdefaultaspx
expand
abil
assess
activ
marker
diseas
detect
follow
cell
surfac
marker
human
antibodi
trial
associ
cellular
adhes
inflamm
leukocyt
extravas
earli
activ
marker
macrophag
activ
marker
altern
macrophag
activ
marker
mhc
class
ii
hladr
origin
includ
identifi
nk
cell
howev
note
express
cell
upregul
diseas
cell
defin
shown
function
cytotox
marmoset
marker
use
expand
previous
publish
work
determin
chang
activ
statu
basic
cell
type
respons
acut
bacteri
infect
anim
challeng
bacteria
compar
dose
either
inhal
n
system
rout
n
human
kill
reach
human
endpoint
day
day
challeng
figur
illustr
cellular
activ
repres
tissu
follow
inhal
figur
b
e
system
challeng
figur
c
f
sampl
figur
nk
cell
appear
similar
rest
activ
state
regardless
origin
wherea
neutrophil
macrophag
differenti
express
activ
exampl
respons
diseas
proport
cell
type
appear
remain
rel
constant
howev
activ
marker
provid
detail
inform
show
involv
cell
type
explor
extens
activ
expect
consid
sampl
taken
human
endpoint
also
extens
variat
sampl
infect
anim
indic
late
time
point
infect
spleen
chosen
repres
organ
system
diseas
cell
activ
show
activ
involv
system
form
diseas
extens
activ
cell
nk
cell
neutrophil
pneumon
form
diseas
neutrophil
macrophag
show
chang
median
valu
respons
infect
within
lung
similar
across
diseas
rout
term
neutrophil
reduc
express
macrophag
increas
express
reduct
mhcii
unexpectedli
nk
cell
appear
activ
involv
system
diseas
indic
diseas
develop
pneumon
element
regardless
initi
rout
infect
level
circul
cytokin
chemokin
rant
also
quantifi
lung
spleen
sampl
cytokin
except
rant
express
high
level
ngmg
sampl
expect
anim
succumb
termin
diseas
work
present
add
signific
relev
inform
marmoset
model
infect
understand
immun
respons
anim
work
extend
marmoset
immunolog
autoimmun
disord
field
infecti
diseas
coupl
increas
inform
avail
crossreact
human
reagent
varieti
nhp
increas
utilityappl
marmoset
model
human
diseas
conclus
immun
respons
marmoset
infecti
diseas
characteris
term
phenotyp
activ
statu
major
immun
cell
key
cytokin
chemokin
express
aid
identif
correl
infect
protect
medic
countermeasur
assess
studi
inform
also
potenti
use
pivot
studi
support
licensur
product
fda
anim
rule
conjunct
small
size
marmoset
immun
respons
infect
compar
human
abil
hous
statist
relev
number
within
high
contain
make
marmoset
appropri
anim
model
biodefenserel
pathogen
